497 related articles for article (PubMed ID: 12077614)
1. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa.
Duerr HP; Eichner M
Int J Parasitol; 2010 May; 40(6):641-50. PubMed ID: 19941867
[TBL] [Abstract][Full Text] [Related]
3. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
Cupp EW; Sauerbrey M; Richards F
Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
[TBL] [Abstract][Full Text] [Related]
4. Control of onchocerciasis.
Boatin BA; Richards FO
Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
[TBL] [Abstract][Full Text] [Related]
5. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
Cupp EW; Cupp MS
Am J Trop Med Hyg; 2005 Dec; 73(6):1159-61. PubMed ID: 16354830
[TBL] [Abstract][Full Text] [Related]
6. Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination.
Alley WS; van Oortmarssen GJ; Boatin BA; Nagelkerke NJ; Plaisier AP; Remme JH; Lazdins J; Borsboom GJ; Habbema JD
BMC Public Health; 2001; 1():12. PubMed ID: 11734070
[TBL] [Abstract][Full Text] [Related]
7. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
[TBL] [Abstract][Full Text] [Related]
8. Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination.
Duerr HP; Raddatz G; Eichner M
Int J Parasitol; 2011 Apr; 41(5):581-9. PubMed ID: 21255577
[TBL] [Abstract][Full Text] [Related]
9. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
[TBL] [Abstract][Full Text] [Related]
10. Filariasis in Africa--treatment challenges and prospects.
Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
[TBL] [Abstract][Full Text] [Related]
11. Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin.
Adewale B; Oyerinde JP; Mafe MA
West Afr J Med; 2008 Oct; 27(4):224-9. PubMed ID: 19469400
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
[TBL] [Abstract][Full Text] [Related]
13. [Human onchocerciasis and "sowda" in the Republic of Yemen].
Richard-Lenoble D; al Qubati Y; Toe L; Pisella PJ; Gaxotte P; al Kohlani A
Bull Acad Natl Med; 2001; 185(8):1447-59; discussion 1459-61. PubMed ID: 11974966
[TBL] [Abstract][Full Text] [Related]
14. Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment.
Hoerauf A; Mand S; Adjei O; Fleischer B; Büttner DW
Lancet; 2001 May; 357(9266):1415-6. PubMed ID: 11356444
[TBL] [Abstract][Full Text] [Related]
15. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.
Boussinesq M; Chippaux JP; Ernould JC; Quillevere D; Prod'hon J
Am J Trop Med Hyg; 1995 Jul; 53(1):63-7. PubMed ID: 7625535
[TBL] [Abstract][Full Text] [Related]
16. Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.
Coffeng LE; Stolk WA; Hoerauf A; Habbema D; Bakker R; Hopkins AD; de Vlas SJ
PLoS One; 2014; 9(12):e115886. PubMed ID: 25545677
[TBL] [Abstract][Full Text] [Related]
17. [The use of ivermectin in the control of onchocerciasis].
Chippaux JP; Boussinesq M; Prod'hon J
Sante; 1995; 5(3):149-58. PubMed ID: 7640897
[TBL] [Abstract][Full Text] [Related]
18. The Onchocerciasis Elimination Program for the Americas (OEPA).
Sauerbrey M
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():25-9. PubMed ID: 18718151
[TBL] [Abstract][Full Text] [Related]
19. Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis.
Stolk WA; Walker M; Coffeng LE; Basáñez MG; de Vlas SJ
Parasit Vectors; 2015 Oct; 8():552. PubMed ID: 26489937
[TBL] [Abstract][Full Text] [Related]
20. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.
Stolk WA; Swaminathan S; van Oortmarssen GJ; Das PK; Habbema JD
J Infect Dis; 2003 Nov; 188(9):1371-81. PubMed ID: 14593597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
